Molecular Profiling and Research of Therapeutic Targets

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


The heterogeneous nature of hepatocellular carcinoma (HCC) poses a challenge to effective therapy. Significant strides have been made in molecular profiling. Telomerase promoter mutations are now known to represent early events in linear carcinogenesis. However, the translation of these advances into clinical practice has been limited. Although further work is needed to extrapolate genetic information to patient care, progress has been made in using genetics and stratification for HCC therapy. Targeted therapies for patients with c-MET overexpression, VEGF-A amplification and Wnt β-catenin-driven tumors offer promise.

Original languageEnglish (US)
Pages (from-to)586-589
Number of pages4
JournalDigestive Diseases
Issue number4
StatePublished - Jul 22 2015


  • Hepatocellular carcinoma
  • Immune modulation
  • Synthetic lethality

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Molecular Profiling and Research of Therapeutic Targets'. Together they form a unique fingerprint.

Cite this